期刊文献+

P63、P504S和Survivin三种标记物联合检测在前列腺病变组织中的表达及意义

The expression of P63, P504S and Survivin in Prostate lesions
原文传递
导出
摘要 目的研究P63、P504S和Survivin在前列腺病变组织中的表达情况以及三种标记物联合应用的诊断价值。方法采用联合免疫组化的方法,对94例不同前列腺病变组织进行P63、P504S和Survivin联合检测。结果30例前列腺良性增生(BPH)组织基底细胞的细胞核P63染色皆呈阳性,前列腺上皮细胞的胞浆P504S和Survivin染色皆呈阴性。61例前列腺癌(PCa)组织基底细胞的细胞核P63染色均呈阴性,细胞浆P504S染色均呈阳性,其阳性表达率为95.31%(61/64);44例前列腺上皮细胞的胞浆Survivin染色呈阳性(包括两例局部显示阳性),其阳性表达率为68.75%(44/64)。三种标记物在BPH和PCa组织中的阳性表达率存在显著差异(P<0.05)。前列腺癌中P504S阳性表达强度明显高于Survivin,同时发现Survivin在癌术后转移组织中的表达较P504S有增强的趋势。结论P63阴性表达和P504S阳性表达是诊断前列腺癌的重要指标,而Survivin阳性表达趋势可能在鉴别诊断原发性和继发性前列腺癌方面具有重要意义,因此P63、P504S和Survivin联合检测可提高前列腺癌诊断的准确性。 Objective To investigate the expression of the P63, P504S and Survivin in prostate and their diagnostic value of the combining detection. Methods Combining Immunohistochemistry was used to detect the expression of P63, P504S and Survivin in 94 cases of differem prostate lesions. Results All the P63 colorations of the basal nucleoli were positive in 30 cases of benign prostatic hypertrophy(BPH) tissues and their P504S and Survivin colorations of the epithelia plasma were negative. All the P63 colorations of the basal nucleoli were negative and the P504S colorations of the prostate epithelia plasma were positive and the positive rate was 95.31% (61/64) in 61 cases of prostatic carcinoma (PCa) tissues; but the Survivin colorations of the prostate epithelia plasma were positive in 44 cases (including two partial positive cases), the positive rate was 68.75% (44/64). Sensitive difference was discovered between the expressions of the three markers in BPH and PCa tissues (P〈0.05). The positive rate of the P504S was obviously higher than the Survivin. The expression of Survivin in the metastatic tissues after operation showed a trend of increase in the operated cases whereas the P504S did not. Conclusion The negative expression of the P63 and the positive expression of the P504S are the important markers for the diagnosis of prostate cancer. The positive expression trend of Survivin is very important in the differential diagnosis between primary PCa and secondary PCa. The combining detection of the P63, P504S and Survivin can improve the accuracy in the diagnoses of PCa.
出处 《中国男科学杂志》 CAS CSCD 2007年第2期21-24,共4页 Chinese Journal of Andrology
基金 湖南省怀化市科学技术局基金资助项目(2005)19号
关键词 P63 P504S SURVIVIN 前列腺癌 P63 P504S Survivin PCa
  • 相关文献

参考文献14

  • 1胡志红,程玲,吴萍,龚勇,黄征,郑美荣.CK34_βE12、p63和p504S联合检测在前列腺肿瘤鉴别诊断中的应用[J].诊断病理学杂志,2005,12(2):123-125. 被引量:20
  • 2Shah RB, Zhou M, LeBlanc M, et al. Comparison of the basal cell-specific markers, 34 beta E12 and P63, in the diagnosis of prostate cancer. Am J Surg Pathol 2002; 26(9): 1161-1168
  • 3Zhou M, Shah R, Shen R, et al. Basal cell cocktail (34 beta E12 + P63) improves the detection of prostate basal cells. Am J Surg Pathol 2003; 27(3): 365-371
  • 4Di Como C J, Urist MJ, Babayan I, et al. P63 expression profiles in human nomal and tumor tissues. Clin Cancer Res 2002; 8(2): 494-501
  • 5Irwin MS, Kaelin WG Jr. Role of the newer p53 family proteins in Malignancy. Apoptosis 2001; 6(1-2): 17-29
  • 6Yang XJ, Wu CL, Woda BA, et al. Expression of alpha-Methylacyl-CoA racemase(P504S) in atypical adenomatous hyperplasia of the prostate. Am J Pathol 2002;26(7): 921-925
  • 7Luo J, Zha S, Wesley R, et al. α-methylacyl-CoA racemase:a new molecular marker for prostate cancer. Cancer Res 2002; 62(8): 2220-2226
  • 8Jiang Z, Woda BA, Rock KL, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 2001; 25(11): 1397-1404
  • 9Iczkowski KA, Jiang Z, Tretiakova M, et al. Prostatic needle biopsies with suspicious(ASAP) diagnosis: 80% resolved using p504s/AMACR and keration 34 β E12 immunostaining.Mod Pathol 2003; 16: 154A
  • 10Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3(8): 917-921

二级参考文献14

  • 1孔祥田,邓方明,王静华,宓培,苏晋伟,夏同礼,郭应禄,顾方六.高分子量细胞角蛋白在前列腺腺癌鉴别诊断中的应用[J].中华病理学杂志,1996,25(4):199-201. 被引量:19
  • 2O'Malley FP,Grignon DJ,Shum DT,et al.Usefiness of immunoperoxidase staining with high-molecular-cytokeratin in the differential diagnosis of small-molecular-actin lesions of the prostate gland[J].Virchows Arch(A),Patnol Anat Histopathol,1990,417(3):191-196.
  • 3Googe PB,Mcgineley KM,Fitzgibbon JF.Anticytokeratin antibody 34βE12 staining in prostate carcinoma[J].Am J Clin Pathol,1997,107:219-232.
  • 4Shah IA,Schlageter MO,Stinnett P,et al.Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate[J].Mod Pathol,1991,4(2):220-224.
  • 5Yang A,Kaghad M,Wang Y,et al.p63 and p53 homolog at 3q27-29,encodes multiple products with transactivating,death-inducing,and dominant-negative activities[J].Mol cell,1998,2(3):305-316.
  • 6Signoretti S,Waltregny D,Dilks J,et al.p63 is a prostate basal cell marker and is required for prostate development[J].Am J pathol,2000,157(6):1769-1775.
  • 7Wojno KJ,Epstein JI.The utility of basal cell-specific anti-cytokeratin antibody (34βE12)in the diagnosis of prostate cancer:a review of 228 cases[J].Am J Surg Pathol,1995,19(3):251-260.
  • 8Zhou M,Shah R,Shen R,et al.Basal cell cock tail(34 beta E12+p63) improves the detection of prostate basal cells[J].Am J Surg Pathol,2003,27(3):365-371.
  • 9Yang XJ,Wu CL,Woda BA,et al.Expression of alpha-methylacyl-CoA racemase(p504S) in athpical adenomatous of the prostate[J].Am J Pathol,2002,26(7):921-925.
  • 10Luo J,Zha SG,Wesley R,et al.Alpha-methylacyl-CoA racemase:a new molecular marker for prostate cancer[J].Cancer Res,2002,62(8):2220-2226.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部